In June, the first part of this article was published, describing differences in the legal background of some of the European Union countries, which need to be known for successful marketing. The second part of the article, by Barbara Siebertz and Ute Hegener at PharmaLex, describes hurdles and requirements regarding the growing, import, and distribution of medicinal cannabis or cannabis-derived products, as well as the potential of this market concerning the development of finished medicinal products as a next step of product development in this evolving market segment.